HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+4.2%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$1.88B
AUM Growth
+$1.88B
(+29%)
Cap. Flow
+$381M
Cap. Flow
% of AUM
20.25%
Top 10 Holdings %
Top 10 Hldgs %
49.83%
Holding
73
New
17
Increased
16
Reduced
12
Closed
18
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$98M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$71.5M |
| 3 |
Agilent Technologies
A
|
$57.4M |
| 4 |
Intuitive Surgical
ISRG
|
$54.4M |
| 5 |
Danaher
DHR
|
$51.6M |
Top Sells
| 1 |
ENDP
Endo International plc
ENDP
|
$52.2M |
| 2 |
Viatris
VTRS
|
$45.1M |
| 3 |
Gilead Sciences
GILD
|
$34.2M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$32.9M |
| 5 |
Merck
MRK
|
$32.7M |
Sector Composition
| 1 | Healthcare | 77.34% |
| 2 | Financials | 4.14% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
1
DELISTED
Veradigm Inc. Common Stock
MDRX
| $148M | 7.4% | 9,200,000 +800,000 | +10% | +$12.8M |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $112M | 5.59% | 500,000 +439,300 | +724% | +$98M |
|
|
MNK
3
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $104M | 5.22% | 1,300,000 +300,000 | +30% | +$24M |
|
|
WMGI
4
DELISTED
Wright Medical Group Inc
WMGI
| $98.9M | 4.96% | 3,150,000 +50,000 | +2% | +$1.57M |
|
|
5
Agilent Technologies
A
$35.7B
| $97.6M | 4.9% | 1,700,000 +1,000,000 | +143% | +$57.4M |
|
|
CBST
6
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $85.5M | 4.29% | 1,225,000 +500,000 | +69% | +$34.9M |
|
|
MDVN
7
DELISTED
MEDIVATION, INC.
MDVN
| $82.9M | 4.16% | 1,075,000 +75,000 | +8% | +$5.78M |
|
|
ALXN
8
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $74.2M | 3.72% | 475,000 +457,700 | +2,646% | +$71.5M |
|
|
CFN
9
DELISTED
CAREFUSION CORPORATION
CFN
| $71M | 3.56% | 1,600,000 +600,000 | +60% | +$26.6M |
|
|
SLXP
10
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $64.8M | 3.25% | 525,000 -125,000 | -19% | -$15.4M |
|
11
eHealth
EHTH
$118M
| $61.7M | 3.09% | 1,625,000 | – | – |
|
|
12
Viatris
VTRS
$12.3B
| $60.6M | 3.04% | 1,175,000 -875,000 | -43% | -$45.1M |
|
|
13
Intuitive Surgical
ISRG
$170B
| $54.4M | 2.73% | +132,200 | New | +$54.4M |
|
14
McKesson
MCK
$85.4B
| $52.5M | 2.63% | 282,100 -67,900 | -19% | -$12.6M |
|
|
15
Danaher
DHR
$147B
| $51.6M | 2.59% | +655,400 | New | +$51.6M |
|
|
NUVA
16
DELISTED
NuVasive, Inc.
NUVA
| $51.6M | 2.59% | 1,450,000 +450,000 | +45% | +$16M |
|
|
CTRX
17
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $50.1M | 2.51% | 1,133,500 +508,500 | +81% | +$22.5M |
|
18
HCA Healthcare
HCA
$94.5B
| $48.8M | 2.45% | +864,900 | New | +$48.8M |
|
|
WBMD
19
DELISTED
WebMD Health Corp.
WBMD
| $47.1M | 2.36% | 975,000 -275,000 | -22% | -$13.3M |
|
|
TSRO
20
DELISTED
TESARO, Inc.
TSRO
| $45.9M | 2.3% | 1,475,000 +75,000 | +5% | +$2.33M |
|
|
HZNP
21
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $42.7M | 2.14% | +2,700,000 | New | +$42.7M |
|
22
Jazz Pharmaceuticals
JAZZ
$7.75B
| $40.7M | 2.04% | +277,000 | New | +$40.7M |
|
|
23
Gilead Sciences
GILD
$140B
| $37.1M | 1.86% | 447,600 -412,892 | -48% | -$34.2M |
|
24
Icon
ICLR
$13.8B
| $36.5M | 1.83% | 775,000 +340,600 | +78% | +$16M |
|
|
25
Merck
MRK
$210B
| $33.8M | 1.69% | 583,900 -566,100 | -49% | -$32.7M |
|